Advertisement

Antiendotoxin Antibody Production of Mononuclear Cells in Multiply Injured Patients

  • K. Buttenschön
  • D. Berger
  • K. Stenzel
  • T. Piper
  • H. G. Beger
Conference paper

Abstract

In 1990 the definition of ‘translocation’ was expanded to include the passage of both viable and nonviable microbes and microbial products across an intact intestinal barrier [1]. Damage to the intestinal barrier causes increased permeability, which is responsible for bacterial components (e.g., endotoxins) entering the circulation [2-4]. Endotoxin is accepted as a potent trigger of the mediator cascade which can cause systemic inflammatory response syndrome (SIRS) and multiple organ failure. Multiply injured patients suffer from temporary endotoxemia, which is most probably due to translocation of endotoxin through the intestinal barrier [5, 6]. Endotoxins are T cell-independent antigens and can stimulate B cells directly [7]. Although there is an acquired immunological deficit after trauma [8], endotoxins are capable of stimulating the synthesis of antiendotoxin antibodies, increasing the amount of the specific IgM antibodies against endotoxins in the serum [5, 6]. However, the concentration of any substance in the blood is a result of production (synthesis or delivery into the blood) and consumption (degradation or removal from the blood). Therefore, this study examined the effect of temporary endotoxemia on peripheral mononuclear cells cultured after blood collection.

Keywords

Systemic Inflammatory Response Syndrome Intestinal Barrier Multiple Injury Vibrio Cholerae Peripheral Mononuclear Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alexander JW, Boyce ST, Babcoek GF (1990) The process of microbial translocation. Ann Surg 212:496–512.PubMedCrossRefGoogle Scholar
  2. 2.
    Baker JW, Deitch EA, Li M, Berg R, Specian R (1988) Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 28:896–906.PubMedCrossRefGoogle Scholar
  3. 3.
    Deitch EA, Morrison J, Berg R, Specian RD (1990) Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit Care Med 18:529–536.PubMedCrossRefGoogle Scholar
  4. 4.
    Van Leeuwen PA, Boermeester MA, Houdijk AP, et al. (1994) Clinical significance of translocation. Gut 35:S28–S34.PubMedCrossRefGoogle Scholar
  5. 5.
    Hiki N, Berger D, Buttenschoen K, et al. (1995) Endotoxemia and specific antibody behavior against different endotoxins following multiple injuries. J Trauma 38:794–801.PubMedCrossRefGoogle Scholar
  6. 6.
    Buttenschoen K, Berger D, Hiki N, Strecker W, Seidelmann M, Beger HG (1996) Plasma concentrations of endotoxin and antiendotoxin antibodies in patients with multiple injuries: a prospective clinical study. Eur J Surg 162:853–860.PubMedGoogle Scholar
  7. 7.
    Feldmann M, Male D (1991) Zellkooperation bei der Antikörperantwort. In: Roitt IM, Brostoff J, Male DK (eds) Kurzes Lehrbuch der Immunologie. Thieme, Stuttgart New York, pp 90–115.Google Scholar
  8. 8.
    Ninnemann JL (1989) The immune consequences of trauma: an overview. In: Faist E, Ninnemann JL, Green D (eds) Immune consequences of trauma, shock, and sepsis. Springer, Berlin Heidelberg New York, pp 1–8.Google Scholar
  9. 9.
    Berger D, Marzinzig E, Marzinzig M, Beger HG (1988) Quantitative endotoxin determination in blood — chromogenic modification of the limulus amebocyte lysate test. Eur Surg Res 20:128–136.PubMedCrossRefGoogle Scholar
  10. 10.
    Machiedo GW, Deitch E A (1991) Case 21: bacteremia of unknown origin. Postgrad Gen Surg 3:147–150.Google Scholar
  11. 11.
    Walker RI (1978) The contribution of intestinal endotoxin to mortality in hosts with compromised resistance: a review. Exp Hematol 6:172–184.PubMedGoogle Scholar
  12. 12.
    O’Mahony JB, Palder SB, Wood JJ, et al. (1984) Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 24:869–875.PubMedCrossRefGoogle Scholar
  13. 13.
    Levitt D, Stull DD, Lawton AR (1981) T-cell-dependent and independent plasma cell differentiation induced by Escherichia coli lipopolysaccaride in human peripheral blood lymphocytes. Clin Immunol Immunopathol 18:309–321.PubMedCrossRefGoogle Scholar
  14. 14.
    Izui S, Eisenberg RA, Dixon FJ (1981) Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccarides. J Exp Med 153:324–338.PubMedCrossRefGoogle Scholar
  15. 15.
    Caridis DT, Reinhold RB, Woodruff PWH, Fine J (1972) Endotoxaemia in Man. Lancet 11:1381–1386.CrossRefGoogle Scholar
  16. 16.
    Moore FA, Moore EE, Poggetti R, et al. (1991) Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 31:629–638.PubMedCrossRefGoogle Scholar
  17. 17.
    Galanos C, Freudenberg MA, Jay F, et al. (1984) Immunogenic properties of lipid A. Rev Infect Dis 6:546–552.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • K. Buttenschön
    • 1
  • D. Berger
    • 1
  • K. Stenzel
    • 1
  • T. Piper
    • 1
  • H. G. Beger
    • 1
  1. 1.Department of SurgeryUniversity of UlmUlmGermany

Personalised recommendations